Body's own defense against ALS actually drives disease progression at later stages

September 11, 2017
Differences in disease progression in spinal interneurons, a type of nerve cell that generally succumbs to ALS in later stages of disease. Left: Normal ALS models, showing protein aggregation (red/green) in spinal interneurons.Right: autophagy-suppressed ALS models, showing virtually no aggregation. Credit: Tom Maniatis/Columbia University's Zuckerman Institute

Columbia scientists have discovered that one of the body's natural defenses against amyotrophic lateral sclerosis (ALS)—a cellular 'clean-up process' called autophagy—suppresses disease progression early on, but in later stages advances the disease's deadly spread through the spinal cord. These findings in mice provide a window into ALS's earliest stages, as well as new insights into its complexity, namely the differing roles that autophagy plays in its progression. In addition, this study can help scientists search for ways to detect and even treat the disease before the onset of devastating symptoms that gradually rob patients of movement, speech and life.

The study is publishing this week in the Proceedings of the National Academy of Sciences.

"One of the biggest barriers to treating ALS is that its progression is dynamic—many different cell types and mechanisms are involved—so treating it at one stage of the might have very different, and potentially harmful, consequences at a different stage," said Tom Maniatis, PhD, a principal investigator at Columbia's Mortimer B. Zuckerman Mind Brain Behavior Institute and the study's senior author. "Here, we've identified a cellular process that likely plays a central role at the very beginnings of the disease, which could open the door to treatments that stop ALS before it has a chance to gain a foothold in the body."

ALS, also referred to as Lou Gehrig's disease, is a deadly disease of the central nervous system for which there is no effective treatment. It first attacks motor neurons, the type of nerve cells that guide muscle movement. As motor neurons die, disease spreads to other types of cells in the spinal cord. Over time, patients increasingly lose their ability to move, to speak and even to breathe on their own. In nearly all instances, patients succumb to ALS within five years of being diagnosed.

Despite the lack of effective therapies, however, much progress has been made in uncovering some of ALS's underlying mechanisms. For example, studies have shown that a common feature of all ALS patients is the abnormal accumulation, or aggregation, of protein clumps inside motor neurons. This accumulation kick starts autophagy, a critical cellular process in which such protein clumps, as well as other damaged parts of the cell, are broken down and removed. In addition, recent studies of ALS led by Columbia geneticist David Goldstein, PhD, revealed mutations in the genes that drives autophagy can cause ALS.

To more precisely explore the role of autophagy in ALS, Dr. Maniatis and his team developed two different groups of ALS mouse models. The first group was genetically modified to mimic the signs of ALS, but were otherwise normal. The second group was identical to the first but with one significant difference: autophagy in their motor neurons was suppressed. The researchers then compared how the disease progressed in these two groups. The differences they observed were unexpected. They found that, in the absence of autophagy, ALS symptoms in the second group of mice advanced more quickly early in the disease, but later on the spread of disease was slower. Remarkably, the mice with suppressed autophagy lived longer than the first group of ALS mice.

"This strongly suggested that even though autophagy may initially stave off disease by suppressing protein aggregation, it eventually hastens the spread of ALS and its devastating symptoms to the rest of the spinal cord," said Dr. Maniatis, who also directs Columbia's Precision Medicine Initiative and is the Isidore S. Edelman Professor and Chair of biochemistry & molecular biophysics at Columbia University Medical Center.

The authors argue that when autophagy is intact, other cell types that surround motor neurons undergo an inflammatory reaction, which soon spreads throughout the , and contributes to the progression of ALS. However, in the absence of autophagy this spread occurs more slowly. They speculate that this may be due to the release of disease-causing protein aggregates that escape from dying during the normal autophagy process. In the absence of autophagy this spread may be diminished.

Autophagy is governed by many genes working in concert across every cell in the body, so Dr. Maniatis and his team are now studying how mutations in these genes affect in their ALS mouse model.

"By the time ALS symptoms are noticeable, the disease is very far along so drugs aren't likely to work unless we can diagnose ALS much earlier—which will be helped by understanding how mutations in genes cause ALS and affect disease progression," said Dr. Maniatis. "If we can find ways of treating the earlier stages of disease, rather than trying to stop it after it's full blown, it may be possible to develop more effective therapies."

Explore further: Link established between a molecular driver of melanoma and novel therapeutic agent

More information: Noam D. Rudnick el al., "Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS," PNAS (2017). www.pnas.org/cgi/doi/10.1073/pnas.1704294114

Related Stories

Link established between a molecular driver of melanoma and novel therapeutic agent

September 7, 2017
Results of a study by The Wistar Institute have described a correlation between a key melanoma signaling pathway and a novel class of drugs being tested in the clinic as adjuvant therapy for advanced melanoma, providing useful ...

Communication between neighboring cells triggers autophagy

June 29, 2017
An immune-related protein deployed between neighboring cells in Drosophila plays an essential role in the cell degradation process known as autophagy, according to new research by Eric H. Baehrecke, PhD, at UMass Medical ...

The benefits of a spotless mind

November 15, 2013
Alzheimer's disease is an age-related memory disorder characterized by the accumulation of clumps of the toxic amyloid-β (Aβ) protein fragment in the extracellular space around neurons in the brain. Drugs that help to 'clean ...

Protein induces self-destruction in cancer cells

January 21, 2015
The role of a phosphatase protein in promoting the self-destruction of healthy cells and the progression of ovarian cancer has been identified by A*STAR researchers. Known to be overexpressed in cancer cells, the protein, ...

Obesity suppresses cellular process critical to kidney health

October 5, 2013
Obesity increases a chronic kidney disease patient's risk of developing kidney failure.

Recommended for you

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

Prototype ear plug sensor could improve monitoring of vital signs

November 16, 2017
Scientists have developed a sensor that fits in the ear, with the aim of monitoring the heart, brain and lungs functions for health and fitness.

Ancient enzyme could boost power of liquid biopsies to detect and profile cancers

November 16, 2017
Scientists are developing a set of medical tests called liquid biopsies that can rapidly detect the presence of cancers, infectious diseases and other conditions from only a small blood sample. Researchers at The University ...

FDA to crack down on risky stem cell offerings

November 16, 2017
U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received ...

Engineering the gut microbiome with 'good' bacteria may help treat Crohn's disease

November 15, 2017
Penn Medicine researchers have singled out a bacterial enzyme behind an imbalance in the gut microbiome linked to Crohn's disease. The new study, published online this week in Science Translational Medicine, suggests that ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

hellenbook8
not rated yet Oct 10, 2017
I have been suffering from amyotrophic laterals sclerosis (ALS) disease for the last three years and had constant pain, especially in my knees. my first sign that something was wrong, was my slurred speech. And then the inability to eat without getting choked, strangled, and coughing.Throughout my three years ordeal, i was able to walk with assistance nothing was really working to help my condition.I went off the riluzole (with the doctor's knowledge) and started on amyotrophic lateral sclerosis herbal formula i ordered from Health Herbal Clinic, Just 7 weeks into the Herbal formula treatment I had great improvements with my slurred speech, there is no case of constant pain and chest tightness since treatment, visit Health Herbal Clinic official website www. healthherbalclinic. net or email info@ healthherbalclinic. net. This treatment is incredible!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.